Posted by Michael Wonder on 06 Dec 2021
TGA provisional approval of Celltrion COVID-19 treatment regdanvimab (Regkirona)
6 December 2021 - On 6 December 2021, the TGA granted provisional approval to Celltrion Healthcare for the use of regdanvimab (Regkirona) for the treatment of COVID-19.
This is the fifth COVID-19 treatment to receive regulatory approval in Australia.
